
- Volume 0 0
MYLAN SCORES VICTORY IN PATENT BATTLE
The latest round in the legal battle over the marketing of generic omeprazole delayedrelease capsules has been won by Mylan Laboratories Inc. A district court in New York ruled that Mylan's generic version of Prilosec does not infringe on AstraZeneca's patents for the popular heartburn drug. At the same time, however, the court held that generic omeprazole products made by 2 other companies, Canada's Apotex Inc and Impax Laboratories Inc in California, do infringe on AstraZeneca's patents.
Articles in this issue
over 18 years ago
pharmacy TECHNOLOGY newsover 18 years ago
pharmacy TECHNOLOGY productsover 18 years ago
health-systems PRODUCT newsover 18 years ago
generic times product newsover 18 years ago
can you READ these Rxs?over 18 years ago
A closer look at new FDA actionsover 18 years ago
can you READ these Rxs?over 18 years ago
compounding HOTLINEover 18 years ago
Is There Science in Quality?over 18 years ago
Vaccines: Are You Protected?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.















































































































































































































